Pillstats
Rx only · Tablet, Film Coated · Oral

Imatinib

Imatinib Mesylate

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01EA01
RxCUI (US)282388
US makers4 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.585$1.17$1.75$2.34Dec 2025Apr 2026Jul 2026
$1.761
Latest avg · Jul 22, 2026
-11%
Since Dec 17, 2025
4
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2164326488642025 Q12025 Q22025 Q32025 Q42026 Q1
109
Rx · 2026 Q1
3.5K
Units dispensed
+85%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Mylan Institutional LLCunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
Mylan Pharmaceuticals Inc.unknown2SUPPLYING
Safecor Health, LLCunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.